Adverse event management

Adverse event management

Bibliographic Details
Main Author:	Aline Gonzalez Vigani
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702007000700020&lng=en&tlng=en

Similar Items

Adverse Events of Oncologic Immunotherapy and Their Management
by: Fedricker Diane Barber
Published: (2019-01-01)

Strategies for improving the management of immune-related adverse events
by: James L Gulley, et al.
Published: (2020-10-01)

Management of immune-related cutaneous adverse events with dupilumab
by: Paul Chapman, et al.
Published: (2023-06-01)

CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN
by: Thais das Neves Fraga MOREIRA, et al.

Emerging Management Approach for the Adverse Events of Immunotherapy of Cancer
by: Md. Mominur Rahman, et al.
Published: (2022-06-01)

Incidents and adverse events notified at hospital level
by: Andreia Mascarello, et al.
Published: (2021-01-01)

The Adverse Event Paradox
by: Thomas Milovac
Published: (2022-05-01)

Evaluation of the Direct Costs of Managing Adverse Drug Events in all Ages and of Avoidable Adverse Drug Events in Older Adults in Japan
by: Hayato Katsuno, et al.
Published: (2021-11-01)

Application of Multidimensional Quality Management Tools in the Management of Medical Adverse Events
by: Yuan B, et al.
Published: (2024-01-01)

General Management Strategies for Efavirenz Therapy and Associated Adverse Events
by: Jean-Guy Baril, et al.
Published: (2006-01-01)

Current landscape and tailored management of immune-related adverse events
by: Wenhui Liu, et al.
Published: (2023-03-01)

Management of adverse events of EUS-directed transgastric ERCP procedure
by: Yervant Ichkhanian, MD, et al.
Published: (2020-06-01)

Oral Immune-Related Adverse Events – Current Concepts and their Management
by: Mohamed Faizal Asan, et al.
Published: (2021-01-01)

Endoscopic management of magnet ingestion and its adverse events in children
by: Radhika Chavan, MD, DNB, et al.
Published: (2022-08-01)

Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
by: Lisa H. Lancaster, et al.
Published: (2017-12-01)

New dosing schedules of dasatinib for CML and adverse event management
by: Wong Siu-Fun
Published: (2009-02-01)

Management of immune checkpoint inhibitor‐related dermatologic adverse events
by: Xiaoyan Si, et al.
Published: (2020-02-01)

Adverse events associated with third space endoscopy: Diagnosis and management
by: Radhika Chavan, et al.
Published: (2020-04-01)

Management of gastrointestinal adverse events induced by immune-checkpoint inhibitors
by: Zheng-Hang Wang, et al.
Published: (2018-03-01)

Management of immune checkpoint inhibitor‐related rheumatic adverse events
by: Jiaxin Zhou, et al.
Published: (2020-01-01)

Blood transfusion adverse event management system: construction and application
by: Xuemin WU, et al.
Published: (2023-11-01)

Management of Rheumatic Adverse Events Related to Immune Checkpoint Inhibitors
by: Jiaxin ZHOU, et al.
Published: (2019-10-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
by: Astri Budikayanti, et al.
Published: (2018-01-01)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
by: Bin Zhao, et al.
Published: (2018-10-01)

Understanding and responding to adverse events.
by: Vincent, C
Published: (2003)

Minor Adverse Events Postcolonoscopy
by: Catherine Dubé
Published: (2014-01-01)

Evaluating adverse events in databases
by: Katie Lovell, et al.
Published: (2023-10-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
by: Wei Mao, et al.
Published: (2025-01-01)

Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
by: Fan Wu, et al.
Published: (2024-06-01)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
by: Kaito Yamashiro, et al.
Published: (2022-10-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
by: Han N, et al.
Published: (2021-08-01)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
by: Dong-Hui Lao, et al.
Published: (2021-06-01)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
by: Bin Zhao, et al.
Published: (2019-01-01)

Adverse Events and Subsequent Management Associated With Eustachian Tube Balloon Dilation
by: Sarah Jeoung, et al.
Published: (2023-07-01)

Establishment of a medical device adverse event management system for hospitals
by: Jing Sun, et al.
Published: (2022-11-01)

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy
by: T. Anders Olsen, et al.
Published: (2022-03-01)

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
by: Uday N. Shivaji, et al.
Published: (2019-11-01)

Dermatologic immune-related adverse events: The toxicity spectrum and recommendations for management
by: Zoe Apalla, PhD, et al.
Published: (2021-12-01)